CN Patent

CN1966500B — 一类喹喔啉类衍生物、制法及用途

Assigned to Shanghai Institute of Materia Medica of CAS · Expires 2011-03-30 · 15y expired

What this patent protects

本发明公开了一类喹喔啉衍生物、及它的制备和用途，该类化合物经生物活性测试，证明它具有JSP-1抑制作用。JSP-1通过活化JNK的上游激酶MKK4和/或MKK7来实现对JNK的活化。JNK途径的异常与许多疾病的病理过程相关，如在炎症性疾病、神经退行性疾病、代谢疾病以及癌症中都发现JNK活性的异常增加，对JNK途径抑制调节可能预防或治疗相关疾病。

USPTO Abstract

本发明公开了一类喹喔啉衍生物、及它的制备和用途，该类化合物经生物活性测试，证明它具有JSP-1抑制作用。JSP-1通过活化JNK的上游激酶MKK4和/或MKK7来实现对JNK的活化。JNK途径的异常与许多疾病的病理过程相关，如在炎症性疾病、神经退行性疾病、代谢疾病以及癌症中都发现JNK活性的异常增加，对JNK途径抑制调节可能预防或治疗相关疾病。

Drugs covered by this patent

Patent Metadata

Patent number
CN1966500B
Jurisdiction
CN
Classification
—
Expires
2011-03-30
Drug substance claim
No
Drug product claim
No
Assignee
Shanghai Institute of Materia Medica of CAS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.